On a routine monitoring visit last Tuesday, the site asked when the TMF/ISF retention clock starts under ICH E6(R2) — LPLV, last marketing authorization in any ICH region, or something else? I promised to pull the citation, so if you have the exact clause (or CFR/EMA equivalents) you rely on during oversight, please share…
Not LPLV — per ICH E6(R2) it’s “2 years after the last approval of a marketing application in an ICH region and until there are no pending or contemplated” applications, or from formal discontinuation, whichever is later (E6 5.5.12; 4.9.5). US mirrors this in 21 CFR 312.62(c)/312.57(c), while EU CTR Art. 58 makes TMF 25 years from end of trial, so default to the longest — think of it as the stopwatch that waits for the last domino; which region is your site in?
After a routine MV like your Tuesday visit, I anchor the site’s retention to a written “records no longer needed” notice, since ICH E6(R2) says the sponsor “should inform the investigator/institution in writing when trial‑related records are no longer needed” (4.9.5/5.5.11). We don’t issue that until Regulatory confirms no pending or contemplated marketing applications across ICH, and for US studies I sanity‑check 21 CFR 312.62(c)/312.57(c) in case the two‑year trigger differs. Do you include that letter in your TMF closeout checklist so monitors can point sites to it in visit reports?
Think two tracks: GCP ties it to a minimum of 2 years after the final approval with no further submissions planned, but under the EU Clinical Trial Regulation the TMF must be kept “for at least 25 years” from end of trial, independent of approval. Practically, I set EU sites to EoT + 25 years and elsewhere wait for the sponsor’s formal release letter before greenlighting destruction. Two clocks on the wall, but only one of them rings loudly in the EU.
Practical step: anchor the site’s timer to a dated sponsor letter stating no further submissions are planned, and file it in the ISF/TMF as the retention trigger; if the study is shelved with no MA, use the documented discontinuation date instead… For EU oversight, this EMA TMF guideline is the one I cite when auditors ask for justification: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-content-management-archiving-clinical-trial-master-file-paper-and/or-electronic_en.pdf — @emmthom, have you seen inspectors accept a program‑level trigger across related protocols? Think of it like starting the kitchen timer only when t.
Not LPLV. For the site, start counting when the sponsor documents “no further filings planned” after the last approval decision, and confirm there aren’t lingering RMP/PASS or label-change commitments that would keep records live. Quick step from your Tuesday visit: file a memo in ISF/TMF mapping that trigger by country and note any minors, since that can extend retention; @charlotte_m92 do you track pediatrics separately?
I handle this by sending a one‑page ‘retention trigger’ memo after RA confirms no further filings, quoting ICH E6(R2) 4.9.5/5.5.11 and 21 CFR 312.62(c)/312.57(c) as the basis for the clock. Since your visit was last Tuesday, drop that memo into the filing index and point to the ICH text here: https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf — want the exact lines I cite?
But in practice, I start counting from the RA note that there are “no pending or contemplated marketing applications in an ICH region” (ICH E6(R2) 4.9.5; https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf), and I drop that quote into the oversight file so the date is unambiguous. Small caveat: if a label extension is still being scoped after the last authorization in any ICH region, I hold the start until that path is closed — curious if you treat a new indication plan as resetting the clock, @RegOpsNina.
Quick example: after a monitoring visit like your last Tuesday one, I ask @RegOps for a one‑line confirmation of the final HA outcome per territory and whether any commitments still touch the study, then set the anchor to the latest territory and stamp it in the eTMF metadata as ‘Retention start: YYYY‑MM‑DD’. Small caveat: if the asset is out‑licensed or the MAH changes later, I don’t shift the date unless the transfer makes us the records holder for the legacy trials. Do you have a place in your eTMF where that anchor is visible to CRAs without digging?